News & Events
-
April 1, 2016
Tuberculosis–Advances in Development of New Drugs, Treatment Regimens, Host-Directed Therapies, and Biomarkers
Wallis RS, Maeurer M, Mwaba P, Chakaya J, Rustomjee R, Migliori GB, Marais B, Schito M, Churchyard G, Swaminathan S, Hoelscher M, Zumla A. Tuberculosis–Advances in Development of New Drugs, Treatment Regimens, Host-Directed Therapies, and Biomarkers. The Lancet Infectious Diseases. 2016 Apr;16(4):e34–46.
- April 1, 2016
-
April 1, 2016
Host-Directed Therapies for Infectious Diseases: Current Status, Recent Progress, and Future Prospects
Zumla A, Rao M, Wallis RS, Kaufmann SHE, Rustomjee R, Mwaba P, Vilaplana C, Yeboah-Manu D, Chakaya J, Ippolito G, Azhar E, Hoelscher M, Maeurer M. Host-Directed Therapies Network consortium. Host-Directed Therapies for Infectious Diseases: Current Status, Recent Progress, and Future Prospects. The Lancet Infectious Diseases. 2016 Apr;16(4):e47–63.
-
March 31, 2016 - April 1, 2016
CAMD Digital Biomarkers Conference
Use of Biosensors in Clinical Trials: Barriers & Solutions to the Current Landscape March 31 – April 1, 2016 Bethesda North Marriott Conference Center Interest in identifying, evaluating and qualifying innovative technologies for use in drug development is growing. While regulatory guidance documents exist for pursuing novel Drug Development Tools (DDTs) and Medical Devices Development... -
March 30, 2016
CDISC, C-Path and TransCelerate Announce Availability of New and Updated Standards for COPD, Virology and Diabetes
March 30, 2016 CDISC, C-Path and TransCelerate Announce Availability of New and Updated Standards for COPD, Virology and Diabetes Austin, TX – 30 March 2016 – The Clinical Data Interchange Standards Consortium (CDISC), the Critical Path Institute (C-Path) and TransCelerate BioPharma, Inc. (“TransCelerate”) today announce the open availability of new and updated CDISC...
